Indications
Symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.
Composition
- Active substance
- glycopyrronium bromide
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Sialanar
- Active substance
- glycopyrronium bromide
- ATC code
- A03AB02
- Therapeutic area
- Sialorrhea
- Marketing authorisation holder
- Proveca Pharma Limited
- Status
- Authorised
- EU authorisation